Overview
- GE HealthCare announced a cash deal to buy Intelerad, aiming to extend cloud-first, AI-enabled imaging across outpatient and hospital settings.
- Completion is targeted for the first half of 2026, subject to regulatory approvals and customary closing conditions.
- Intelerad is projected to deliver about $270 million in first full-year revenue with roughly 90% recurring and an adjusted EBITDA margin above 30%, with low double-digit growth.
- GE HealthCare expects the transaction to be immediately accretive to top-line growth and Adjusted EBIT margin and forecasts a high-single-digit ROIC by year five.
- The combined offering targets the high-growth outpatient enterprise imaging market estimated above $2 billion, with GE planning to fund the purchase using cash on hand and new debt.